Confirma Receives the 2006 Frost & Sullivan Industry Innovation and Advancement Award; Company Recognized for Its Technology Innovation, Adoption of Products, Marketing Strategies and Customer Service
Posted on: Tuesday, 18 July 2006, 12:00 CDT
Confirma, Inc., leading provider of computer-aided-detection (CAD) for breast MRI, today announced it has been recognized by Frost & Sullivan with the 2006 Industry Innovation and Advancement Award for the U.S. computer-aided-detection (CAD) market. Frost & Sullivan, a global growth consulting company, presents the Industry Innovation and Advancement Award based on a company's leadership, technological innovation, customer service and strategic product development.
"To be awarded the 2006 Industry Innovation and Advancement Award, a company must demonstrate outstanding achievement and superior performance in the marketplace," said Laura Kramer, research analyst, Frost & Sullivan. "We proudly honor Confirma for pioneering and continuing to improve efficiency and analysis in breast MRI. Confirma has dramatically contributed to the adoption of breast MRI CAD in the medical imaging community."
CADstream(TM) is advancing breast MRI by enhancing efficiency, standardization, access and compatibility of studies. The system automates analysis, reporting and interventional planning of studies and promotes standardization with the incorporation of the ACR BI-RADS(R) Atlas. CADstream is designed for any workflow scenario, integrating with existing equipment and providing access to studies anywhere on the network. Automated features include adaptive image registration (2D/3D), multiplanar reformatting, subtractions, angiogenesis maps, curves, maximum intensity projections (MIPs), volume summaries, morphology characterization, Portfolio for reporting, SureLoc(TM) for interventional guidance and multimodality capability.
"Confirma is dedicated to delivering products that advance breast MRI, ultimately improving breast cancer detection for patients. With over 500 CADstream systems integrated into imaging programs, we have learned a great deal, and we have adapted and built products that exceed physicians' needs for providing premium care," said Wayne Wager, president and CEO, Confirma, Inc. "We are proud of this accomplishment and honored to receive this award from Frost & Sullivan."
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com.
About Confirma, Inc.
Confirma, Inc. develops and markets CAD systems and accessories for medical imaging. CADstream(TM) is the standard in CAD for magnetic resonance imaging (MRI). CADstream automates the processing of MRI studies, providing higher quality imaging studies, lower costs for radiology practices and improved communication tools for physicians and patients. In its initial application, CADstream is being used to assist in the analysis, interventional guidance and reporting of breast MRI studies. CADstream is DICOM 3.0 compliant, allowing integration with any MRI scanner and PACS. Confirma has established partnerships with companies including GE Healthcare, Philips Medical Systems, Hologic, iCAD and Vital Images. Confirma has partnered with hundreds of imaging centers and corporate partners worldwide since 2003, helping develop more standardized, high performance breast MRI programs that deliver premium patient care. For more information, visit www.confirma.com or call 877-811-2356.
Source: Business Wire
Related Articles
- Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
- Women's Digital Imaging of Ridgewood First Private Medical Practice in New York Area to Screen With Breast Specific Gamma Imaging (BSGI)
- Further Testing With Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Cancer in Breast Cancer Patients, Changes Surgical Management
- Breast-Specific Gamma Imaging (BSGI) Can Reduce the Number of Unnecessary Breast Biopsies When Compared to MRI
- Breast-Specific Gamma Imaging (BSGI) Offers Greater Sensitivity Over Mammography, Ultrasound and MRI
- Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
- Breast-Specific Gamma Imaging (BSGI) Changes Patient Care Management
- Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms
- Breast Cancer Research is Studied
- In Brazil Seven Out of Ten Purchases at Drugstores Are Not Sold Under a Doctors' Prescription Therefore the Success of a New Drug or New Concept is Only Partially in the Hands of Doctors - The Image of Pharmaceutical Industry in Brazil
 |
 |
User Comments (0)
RSS Feeds